13F HOLDINGS REPORT
Sands Capital Ventures, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001846444-26-000003
Total Value
$518.5M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KLAVIYO INC | KVYO | 3,649,678 | $118.5M | 22.86% |
| 2 | NU HLDGS LTD | NU | 6,861,399 | $114.9M | 22.15% |
| 3 | BETA BIONICS INC | BBNX | 3,570,113 | $108.8M | 20.98% |
| 4 | INHIBIKASE THERAPEUTICS INC | IKT | 13,018,965 | $26.7M | 5.15% |
| 5 | DOORDASH INC | DASH | 95,618 | $21.7M | 4.18% |
| 6 | COUPANG INC | CPNG | 870,424 | $20.5M | 3.96% |
| 7 | SAMSARA INC | IOT | 466,190 | $16.5M | 3.19% |
| 8 | DATADOG INC | DDOG | 85,793 | $11.7M | 2.25% |
| 9 | TOAST INC | TOST | 301,647 | $10.7M | 2.07% |
| 10 | BIOAGE LABS INC | BIOA | 786,353 | $10.4M | 2.01% |
| 11 | MONDAY COM LTD | MNDY | 67,868 | $10.0M | 1.93% |
| 12 | SERVICETITAN INC | TTAN | 89,856 | $9.6M | 1.85% |
| 13 | 10X GENOMICS INC | TXG | 481,770 | $7.9M | 1.52% |
| 14 | ACUMEN PHARMACEUTICALS INC | ABOS | 3,417,075 | $7.2M | 1.39% |
| 15 | TARSUS PHARMACEUTICALS INC | TARS | 85,000 | $7.0M | 1.34% |
| 16 | ACRIVON THERAPEUTICS INC | ACRV | 2,122,605 | $5.1M | 0.99% |
| 17 | SNOWFLAKE INC | SNOW | 20,253 | $4.4M | 0.86% |
| 18 | TAYSHA GENE THERAPIES INC | TSHA | 724,873 | $4.0M | 0.77% |
| 19 | CANDEL THERAPEUTICS INC | CADL | 405,837 | $2.3M | 0.44% |
| 20 | FIGMA INC | FIG | 18,286 | $683,348 | 0.13% |